Terms: = Prostate cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
22 results:
1. The Molecular Mechanism and Therapeutic Application of Autophagy for Urological Disease.
Chueh KS; Lu JH; Juan TJ; Chuang SM; Juan YS
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834333
[TBL] [Abstract] [Full Text] [Related]
2. The
Gupta N; Song H; Wu W; Ponce RK; Lin YK; Kim JW; Small EJ; Feng FY; Huang FW; Okimoto RA
Elife; 2022 Nov; 11():. PubMed ID: 36383412
[TBL] [Abstract] [Full Text] [Related]
3. Indications and Outcomes for Intermittent Catheterization following Bulbar AUS Cuff Placement.
Krughoff K; Livingston AJ; Inouye B; Peterson AC; Lentz AC
Urology; 2023 Jan; 171():216-220. PubMed ID: 36332702
[TBL] [Abstract] [Full Text] [Related]
4. Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantation.
Drevik JA; Dalimov Z; Lucas J; Simhan J; Cohn JA
Int J Impot Res; 2024 May; 36(3):201-205. PubMed ID: 36198809
[TBL] [Abstract] [Full Text] [Related]
5. Urinary Outcomes After Magnetic Resonance Imaging-Guided Whole-Gland Transurethral Ultrasound Ablation for prostate cancer: Comparison of Suprapubic Tube to Indwelling Urethral Catheter.
Rabinowitz MJ; Haney NM; Myers AA; Dora CD; Pavlovich CP
J Endourol; 2023 Jan; 37(1):1-7. PubMed ID: 36017622
[No Abstract] [Full Text] [Related]
6. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in prostate cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract] [Full Text] [Related]
7. Best nonsurgical managements of acute urinary retention: what's new?
Baboudjian M; Peyronnet B; Boissier R; Robert G; Cornu JN; Misrai V; Pradere B
Curr Opin Urol; 2022 Mar; 32(2):124-130. PubMed ID: 34954701
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptomic analysis of cic and ATXN1L reveal a functional relationship exploited by cancer.
Wong D; Lounsbury K; Lum A; Song J; Chan S; LeBlanc V; Chittaranjan S; Marra M; Yip S
Oncogene; 2019 Jan; 38(2):273-290. PubMed ID: 30093628
[TBL] [Abstract] [Full Text] [Related]
9. Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human prostate cancer Cell Lines.
Seim I; Jeffery PL; Thomas PB; Nelson CC; Chopin LK
G3 (Bethesda); 2017 Jun; 7(6):1731-1741. PubMed ID: 28413162
[TBL] [Abstract] [Full Text] [Related]
10. miR-93/miR-106b/miR-375-cic-CRABP1: a novel regulatory axis in prostate cancer progression.
Choi N; Park J; Lee JS; Yoe J; Park GY; Kim E; Jeon H; Cho YM; Roh TY; Lee Y
Oncotarget; 2015 Sep; 6(27):23533-47. PubMed ID: 26124181
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of postoperative urinary retention after male sling insertion.
Hall M; Polland A; Weissbart S; Mock S; Grafstein N
Can J Urol; 2014 Aug; 21(4):7344-9. PubMed ID: 25171276
[TBL] [Abstract] [Full Text] [Related]
12. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
[TBL] [Abstract] [Full Text] [Related]
13. Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.
Chen S; Principessa L; Isaacs JT
Prostate; 2012 Sep; 72(13):1478-89. PubMed ID: 22396312
[TBL] [Abstract] [Full Text] [Related]
14. PSA levels in men with spinal cord injury and under intermittent catheterization.
Torricelli FC; Lucon M; Vicentini F; Gomes CM; Srougi M; Bruschini H
Neurourol Urodyn; 2011 Nov; 30(8):1522-4. PubMed ID: 21661042
[TBL] [Abstract] [Full Text] [Related]
15. Targeting the cancer initiating cell: the Achilles' heel of cancer.
McCubrey JA; Chappell WH; Abrams SL; Franklin RA; Long JM; Sattler JA; Kempf CR; Laidler P; Steelman LS
Adv Enzyme Regul; 2011; 51(1):152-62. PubMed ID: 21035484
[TBL] [Abstract] [Full Text] [Related]
16. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
Vander Griend DJ; D'Antonio J; Gurel B; Antony L; Demarzo AM; Isaacs JT
Prostate; 2010 Jan; 70(1):90-9. PubMed ID: 19790235
[TBL] [Abstract] [Full Text] [Related]
17. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
[TBL] [Abstract] [Full Text] [Related]
18. Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
[TBL] [Abstract] [Full Text] [Related]
19. The presence and structure of circulating immune complexes in patients with prostate tumors.
Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
[TBL] [Abstract] [Full Text] [Related]
20. Sexuality preserving cystectomy and neobladder (SPCN): functional results of a neobladder anastomosed to the prostate.
Meinhardt W; Horenblas S
Eur Urol; 2003 Jun; 43(6):646-50. PubMed ID: 12767366
[TBL] [Abstract] [Full Text] [Related]
[Next]
